Carisma Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning, and welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Dave Praharaj and part of the healthcare investment banking team here at JP Morgan. Today, I have the pleasure of introducing our speaker, Steve Kelly, CEO of Carisma Therapeutics. In terms of logistics, Please reserve any questions for after their presentations, and Mic will be passed around, with that take it away Steve.
Thanks, Dave. Good morning everyone, and also thanks to JPMorgan for adding us to the agenda. Really appreciate the opportunity to present the story of Carisma, Carisma is a cell therapy company focused on macrophages.
We've pioneered this space and we believe that we are in position to take the power of the macrophage cell innate immune cell that has broad applicability and orchestrates the adaptive immune response, we can apply that power to a variety of different diseases.
First, oncology, there's unmet medical need
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
